EMA
guidance
· 2018-03-23
New measures to avoid valproate exposure in pregnancy endorsed
Summary
EU endorses new measures to avoid valproate exposure in pregnancy, reinforcing restrictions due to teratogenic risk.
Upgrade for the full analysis, importance score, and drug timeline.